pembrolizumab
merck
['keytruda', 'lung', 'nsclc', 'sclc']
#merk announced 5-year survival data of #keytruda from two studies in patients with #nsclc. #esmo22 #esmo2022 #onctwitter #cancer #oncology #news #media #medtwitter #news #media #conferences #esmo #globalhealth #lungcancer #lungs #patientcare
iPharmaCenter is a #website which covers #pharmaceutical and #healthcare #news plus #blogs #diseases #drugs #healthcaresystems #globalhealth #pharma